UNSPSC 51241800: Combination dermatologicals

This classification denotes combination drugs and preparations that treat or prevent skin disorders or for the routine care of skin, or the dermis, hence the term DERMATOLOGICALS. Typical combination dermatological constituents are allantoin, bacitracin, calamine, dimethicone, glycerin, hamamelis water, iodine, ketoconazole, lanolin, and menthol.

UNSPSC 51241800 Combination dermatologicals, a Class code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code appears in current solicitations for unrelated commodity purchases that fall outside the dermatological product family entirely. The City of Austin's IFB for liquid aluminum sulfate (alum) and the City of Tampa Fire Rescue's ITB for medical aid supplies—both posted in 2026—represent the recent opportunities tagged to this code, but neither involves combination dermatological products. The Austin solicitation targets chemical treatment materials for wastewater phosphorus removal at municipal water treatment facilities; the Tampa solicitation covers first aid and emergency medical supplies including antiseptic sprays, hydrogen peroxide, bandages, and emergency blankets for fire rescue operations. State and local procurement offices appear to be using this code to classify commodity supplies broadly rather than dermatological products specifically.

The code shows recent activity from city-level issuing bodies in Texas and Florida, with the Austin and Tampa procurement offices each posting one solicitation in the past six months. The Austin IFB carries a response deadline of August 25, 2026, and includes local and small business preference discounts (5% for local businesses; small business preferences may stack); the Tampa ITB, due April 9, 2025 (predating the current date), encompasses a $100,000 departmental budget and includes set-asides for City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises with bid discounts up to 5%. Neither solicitation reflects procurement patterns typical of dermatological supply chains, suggesting either data-classification inconsistency or a fundamental mismatch between code scope and actual buying activity under this code in state and local markets.